Last update: Dec. 26, 2020
Minimal risk for breastfeeding and infant.
Amniocentesis and chorion biopsy are invasive prenatal diagnostic techniques whose purpose is to rule out a congenital defect during pregnancy, whether it is chromosomal or not.
The risk of fetal loss or miscarriage following invasive prenatal diagnostic techniques is less than 1% (Mayo Clinic 2019, SJD 2019, SCH 2019, SEGO 2018, Ghi 2016, AEP 2015, Cruz 2014, SOGC 2015 and 2005).
After the test is carried out, most gynecology and obstetrics associations, clinical guidelines and protocols from prestigious hospitals recommend (with very little evidence) resting at home and avoiding excessive exercise for one or two days (Mayo Clinic 2019, SJD 2019, Dexeus 2019, MBMC 2019, SCH 2019, SEGO 2018 and 2013, Ghi 2016, AEP 2015, Cruz 2014, SOGC 2015 and 2005) and some also advise sexual abstinence during that period (Mayo Clinic 2019, Dexeus 2019, AEP 215).
None of the sources consulted recommends abstaining from breastfeeding; some, on the contrary, advise continuing breastfeeding (CLM-AEP 2011).
Since the last update we have not found any published data that support the discontinuing of breastfeeding after the test.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2006 from United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM